The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma
- PMID: 1173821
- DOI: 10.1007/BF01066017
The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma
Abstract
A mathematical model is presented to simulate the time-dependent uptake of methotrexate in spontaneous canine lymphosarcomas in vivo. Blood flow ratew in these tumors are high so that transport to the tumor is limited by cell membrane resistance. A significant amount of rapidly exchangeable methotrexate appears to exist in extracellular space loosely bound to proteins or cell membranes. Transmembrane drug transport follows Michaelis-Menten kinetics, wigh the maximum facilitated transport ranging from 0.002 to 0.007 mug/min/ml for the separate tumors studied and a Michaelis constant for transport equal to 0.2 mug/ml. This is in the range of Michaelis constants reported for normal tissues in rats in vivo and in several cell linnes in vitro.
Similar articles
-
Distribution of anticancer agents in spontaneous animal tumors. I. Regional blood flow and methotrexate distribution in canine lymphosarcoma.J Natl Cancer Inst. 1974 Apr;52(4):1327-31. doi: 10.1093/jnci/52.4.1327. J Natl Cancer Inst. 1974. PMID: 4406459 No abstract available.
-
In vivo methotrexate transport in murine Lewis lung tumor.J Pharm Sci. 1979 Aug;68(8):941-5. doi: 10.1002/jps.2600680806. J Pharm Sci. 1979. PMID: 480171
-
Studies with a 2,4-diamino-5-chloro-quinazoline antifolate: in vitro and invivo correlates in normal and lymphosarcoma dogs.Ann N Y Acad Sci. 1971 Nov 30;186:501-13. doi: 10.1111/j.1749-6632.1971.tb47006.x. Ann N Y Acad Sci. 1971. PMID: 5289430 No abstract available.
-
The cellular pharmacology of methotrexate.Pharmacol Ther. 1985;28(1):77-102. doi: 10.1016/0163-7258(85)90083-x. Pharmacol Ther. 1985. PMID: 2414788 Review. No abstract available.
-
The pharmacology and clinical use of methotrexate.N Engl J Med. 1983 Nov 3;309(18):1094-104. doi: 10.1056/NEJM198311033091805. N Engl J Med. 1983. PMID: 6353235 Review. No abstract available.
Cited by
-
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate.J Pharmacokinet Pharmacodyn. 2014 Apr;41(2):159-71. doi: 10.1007/s10928-014-9354-4. Epub 2014 Mar 21. J Pharmacokinet Pharmacodyn. 2014. PMID: 24651961
-
A pharmacokinetic model for high-dose methotrexate infusions in man.J Pharmacokinet Biopharm. 1977 Oct;5(5):421-33. doi: 10.1007/BF01061726. J Pharmacokinet Biopharm. 1977. PMID: 925879 No abstract available.
-
Physiologically based pharmacokinetic models for anticancer drugs.Cancer Chemother Pharmacol. 1979;2(2):85-94. doi: 10.1007/BF00254079. Cancer Chemother Pharmacol. 1979. PMID: 93986 Review.
-
Pharmacokinetics of methotrexate in solid tumors.J Pharmacokinet Biopharm. 1979 Apr;7(2):181-94. doi: 10.1007/BF01059737. J Pharmacokinet Biopharm. 1979. PMID: 20218013
-
Pharmacokinetics of sulfaethidole in the rat: nonlinear multicompartment solution.J Pharmacokinet Biopharm. 1982 Feb;10(1):27-51. doi: 10.1007/BF01059182. J Pharmacokinet Biopharm. 1982. PMID: 6896071